|
PMPCB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.406500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.037610E-03 |
| Normal-vs-Stage2 |
8.242000E-01 |
| Normal-vs-Stage3 |
1.021260E-03 |
| Normal-vs-Stage4 |
2.362100E-03 |
| Stage1-vs-Stage2 |
6.291900E-02 |
| Stage1-vs-Stage3 |
5.586200E-01 |
| Stage1-vs-Stage4 |
6.574200E-01 |
| Stage2-vs-Stage3 |
4.357500E-02 |
| Stage2-vs-Stage4 |
5.377900E-02 |
| Stage3-vs-Stage4 |
9.586200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.575600E-04 |
| Normal-vs-AfricanAmerican |
1.167040E-01 |
| Normal-vs-Asian |
6.404700E-03 |
| Caucasian-vs-AfricanAmerican |
5.037000E-01 |
| Caucasian-vs-Asian |
9.054800E-01 |
| AfricanAmerican-vs-Asian |
5.173200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.037700E-03 |
| Normal-vs-Female |
1.318960E-03 |
| Male-vs-Female |
7.244600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.279920E-03 |
| Normal-vs-Age(41-60Yrs) |
3.204800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.319600E-02 |
| Normal-vs-Age(81-100Yrs) |
3.504500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.645800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.861600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.673600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.607600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.782800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.258200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.094200E-02 |
| Classical-VS-Follicular |
7.654600E-01 |
| Classical-VS-Other |
4.832200E-01 |
| Classical-VS-Normal |
6.178800E-03 |
| Tall-VS-Follicular |
4.421900E-02 |
| Tall-VS-Other |
6.940200E-01 |
| Tall-VS-Normal |
1.801620E-04 |
| Follicular-VS-Other |
5.660800E-01 |
| Follicular-VS-Normal |
7.248200E-02 |
| Other-VS-Normal |
7.285900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.259200E-03 |
| Normal-vs-N1 |
2.213100E-04 |
| N0-vs-N1 |
7.550500E-02 |
|
|
